In a word, PI3K/AKT/EGFR and MAPK signaling pathways play a crucial role in cancer cell proliferation and tumor progression, and a previous study has confirmed that EGFR is a target for TNBC treatment (Liao et al., 2019). Here, AKT1 is linked to neoplasm.